{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:40:08Z","timestamp":1789663208823,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T00:00:00Z","timestamp":1517616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1716\/11"],"award-info":[{"award-number":["1716\/11"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000912","name":"March of Dimes Foundation","doi-asserted-by":"publisher","award":["5-FY12-55"],"award-info":[{"award-number":["5-FY12-55"]}],"id":[{"id":"10.13039\/100000912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011264","name":"FP7 People: Marie-Curie Actions","doi-asserted-by":"publisher","award":["PEOPLE-2010-IR"],"award-info":[{"award-number":["PEOPLE-2010-IR"]}],"id":[{"id":"10.13039\/100011264","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s10456-018-9595-8","type":"journal-article","created":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T11:12:06Z","timestamp":1517656326000},"page":"287-298","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Somatic NRAS mutation in patient with generalized lymphatic anomaly"],"prefix":"10.1007","volume":"21","author":[{"given":"Eugenia","family":"Manevitz-Mendelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil S.","family":"Leichner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ortal","family":"Barel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbal","family":"Davidi-Avrahami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limor","family":"Ziv-Strasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran","family":"Eyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itai","family":"Pessach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Rimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviv","family":"Barzilai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Hirshberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Chechekes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninette","family":"Amariglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Rechavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Yaniv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoshana","family":"Greenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,3]]},"reference":[{"key":"9595_CR1","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1542\/peds.2014-3673","volume":"136","author":"M Wassef","year":"2015","unstructured":"Wassef M, Blei F, Adams D et al (2015) Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics 136:e203\u2013e214","journal-title":"Pediatrics"},{"key":"9595_CR2","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1164\/ajrccm.161.3.9904056","volume":"161","author":"JL Faul","year":"2000","unstructured":"Faul JL, Berry GJ, Colby TV et al (2000) Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome. Am J Respir Crit Care Med 161:1037\u20131046","journal-title":"Am J Respir Crit Care Med"},{"key":"9595_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2214\/ajr.164.2.7839977","volume":"164","author":"MJ Kransdorf","year":"1995","unstructured":"Kransdorf MJ (1995) Benign soft-tissue tumors in a large referral population: distribution of specific diagnoses by age, sex, and location. AJR Am J Roentgenol 164:395\u2013402","journal-title":"AJR Am J Roentgenol"},{"key":"9595_CR4","first-page":"52","volume":"20","author":"KC Kadakia","year":"2013","unstructured":"Kadakia KC, Patel SM, Yi ES, Limper AH (2013) Diffuse pulmonary lymphangiomatosis. Can Resp J J Can Thorac Soc 20:52\u201354","journal-title":"Can Resp J J Can Thorac Soc"},{"key":"9595_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1053\/j.sempedsurg.2014.07.006","volume":"23","author":"CC Trenor 3rd","year":"2014","unstructured":"Trenor CC 3rd, Chaudry G (2014) Complex lymphatic anomalies. Semin Pediatr Surg 23:186\u2013190","journal-title":"Semin Pediatr Surg"},{"key":"9595_CR6","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1542\/peds.86.6.988","volume":"86","author":"RI Hilliard","year":"1990","unstructured":"Hilliard RI, McKendry JB, Phillips MJ (1990) Congenital abnormalities of the lymphatic system: a new clinical classification. Pediatrics 86:988\u2013994","journal-title":"Pediatrics"},{"key":"9595_CR7","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1056\/NEJMc1013217","volume":"364","author":"M Ozeki","year":"2011","unstructured":"Ozeki M, Fukao T, Kondo N (2011) Propranolol for intractable diffuse lymphangiomatosis. N Engl J Med 364:1380\u20131382","journal-title":"N Engl J Med"},{"key":"9595_CR8","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1016\/j.mayocp.2014.05.020","volume":"89","author":"A Bassi","year":"2014","unstructured":"Bassi A, Syed S (2014) Multifocal infiltrative lymphangiomatosis in a child and successful treatment with sirolimus. Mayo Clin Proc 89:e129","journal-title":"Mayo Clin Proc"},{"key":"9595_CR9","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/lary.21927","volume":"121","author":"J Reinglas","year":"2011","unstructured":"Reinglas J, Ramphal R, Bromwich M (2011) The successful management of diffuse lymphangiomatosis using sirolimus: a case report. Laryngoscope 121:1851\u20131854","journal-title":"Laryngoscope"},{"key":"9595_CR10","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/nprot.2008.71","volume":"3","author":"JR Beijnum van","year":"2008","unstructured":"van Beijnum JR, Rousch M, Castermans K, van der Linden E, Griffioen AW (2008) Isolation of endothelial cells from fresh tissues. Nat Protoc 3:1085\u20131091","journal-title":"Nat Protoc"},{"key":"9595_CR11","first-page":"e51312","volume":"91","author":"KL DeCicco-Skinner","year":"2014","unstructured":"DeCicco-Skinner KL, Henry GH, Cataisson C et al (2014) Endothelial cell tube formation assay for the in vitro study of angiogenesis. J Vis Exp 91:e51312","journal-title":"J Vis Exp"},{"key":"9595_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature14425","volume":"522","author":"J Nicenboim","year":"2015","unstructured":"Nicenboim J, Malkinson G, Lupo T et al (2015) Lymphatic vessels arise from specialized angioblasts within a venous niche. Nature 522:56\u201361","journal-title":"Nature"},{"key":"9595_CR13","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nm.2759","volume":"18","author":"I Avraham-Davidi","year":"2012","unstructured":"Avraham-Davidi I, Ely Y, Pham VN et al (2012) ApoB-containing lipoproteins regulate angiogenesis by modulating expression of VEGF receptor 1. Nat Med 18:967\u2013973","journal-title":"Nat Med"},{"key":"9595_CR14","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1242\/dev.077701","volume":"139","author":"KS Okuda","year":"2012","unstructured":"Okuda KS, Astin JW, Misa JP, Flores MV, Crosier KE, Crosier PS (2012) lyve1 expression reveals novel lymphatic vessels and new mechanisms for lymphatic vessel development in zebrafish. Development 139:2381\u20132391","journal-title":"Development"},{"key":"9595_CR15","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1002\/dvdy.21354","volume":"236","author":"JA Villefranc","year":"2007","unstructured":"Villefranc JA, Amigo J, Lawson ND (2007) Gateway compatible vectors for analysis of gene function in the zebrafish. Dev Dyn 236:3077\u20133087","journal-title":"Dev Dyn"},{"key":"9595_CR16","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa0903036","volume":"362","author":"S Greenberger","year":"2010","unstructured":"Greenberger S, Boscolo E, Adini I, Mulliken JB, Bischoff J (2010) Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells. N Engl J Med 362:1005\u20131013","journal-title":"N Engl J Med"},{"key":"9595_CR17","doi-asserted-by":"crossref","unstructured":"Greenberger S, Yuan S, Walsh LA, Boscolo E, Kang KT, Matthews B, Mulliken JB, Bischoff J (2011) Rapamycin suppresses self-renewal and vasculogenic potential of stem cells isolated from infantile hemangioma. J Invest Dermatol 131:2467\u20132476","DOI":"10.1038\/jid.2011.300"},{"key":"9595_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1161\/CIRCRESAHA.108.178590","volume":"103","author":"JM Melero-Martin","year":"2008","unstructured":"Melero-Martin JM, De Obaldia ME, Kang SY et al (2008) Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res 103:194\u2013202","journal-title":"Circ Res"},{"key":"9595_CR19","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/01.mph.0000193476.14493.06","volume":"27","author":"Z Tamay","year":"2005","unstructured":"Tamay Z, Saribeyoglu E, Ones U et al (2005) Diffuse thoracic lymphangiomatosis with disseminated intravascular coagulation in a child. J Pediatr Hematol Oncol 27:685\u2013687","journal-title":"J Pediatr Hematol Oncol"},{"key":"9595_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/lrb.2011.0023","volume":"9","author":"MN Satria","year":"2011","unstructured":"Satria MN, Pacheco-Rodriguez G, Moss J (2011) Pulmonary lymphangiomatosis. Lymphat Res Biol 9:191\u2013193","journal-title":"Lymphat Res Biol"},{"key":"9595_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00441-008-0644-2","volume":"335","author":"G Jurisic","year":"2009","unstructured":"Jurisic G, Detmar M (2009) Lymphatic endothelium in health and disease. Cell Tissue Res 335:97\u2013108","journal-title":"Cell Tissue Res"},{"key":"9595_CR22","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.cell.2010.01.045","volume":"140","author":"T Tammela","year":"2010","unstructured":"Tammela T, Alitalo K (2010) Lymphangiogenesis: molecular mechanisms and future promise. Cell 140:460\u2013476","journal-title":"Cell"},{"key":"9595_CR23","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1038\/jid.2012.186","volume":"132","author":"A Li","year":"2012","unstructured":"Li A, Ma Y, Jin M et al (2012) Activated mutant NRas(Q61\u00a0K) drives aberrant melanocyte signaling, survival, and invasiveness via a Rac1-dependent mechanism. J Investig Dermatol 132:2610\u20132621","journal-title":"J Investig Dermatol"},{"key":"9595_CR24","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1146\/annurev.immunol.24.021605.090723","volume":"24","author":"A Mor","year":"2006","unstructured":"Mor A, Philips MR (2006) Compartmentalized Ras\/MAPK signaling. Annu Rev Immunol 24:771\u2013800","journal-title":"Annu Rev Immunol"},{"key":"9595_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.critrevonc.2014.05.005","volume":"92","author":"M Mandala","year":"2014","unstructured":"Mandala M, Merelli B, Massi D (2014) Nras in melanoma: targeting the undruggable target. Crit Rev Oncol\/Hematol 92:107\u2013122","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"9595_CR26","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/pbc.23124","volume":"57","author":"AM Hammill","year":"2011","unstructured":"Hammill AM, Wentzel M, Gupta A et al (2011) Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer 57:1018\u20131024","journal-title":"Pediatr Blood Cancer"},{"key":"9595_CR27","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s00431-015-2572-y","volume":"174","author":"H Lackner","year":"2015","unstructured":"Lackner H, Karastaneva A, Schwinger W et al (2015) Sirolimus for the treatment of children with various complicated vascular anomalies. Eur J Pediatr 174:1579\u20131584","journal-title":"Eur J Pediatr"},{"issue":"2","key":"9595_CR28","doi-asserted-by":"publisher","first-page":"e20153257","DOI":"10.1542\/peds.2015-3257","volume":"137","author":"DM Adams","year":"2016","unstructured":"Adams DM, Trenor CC, Hammill AM et al (2016) Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics 137(2):e20153257","journal-title":"Pediatrics"},{"key":"9595_CR29","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1093\/annonc\/mdq331","volume":"21","author":"TG Grunewald","year":"2010","unstructured":"Grunewald TG, Damke L, Maschan M et al (2010) First report of effective and feasible treatment of multifocal lymphangiomatosis (Gorham-Stout) with bevacizumab in a child. Ann Oncol 21:1733\u20131734","journal-title":"Ann Oncol"},{"key":"9595_CR30","doi-asserted-by":"publisher","first-page":"839","DOI":"10.7326\/0003-4819-156-11-201206050-00016","volume":"156","author":"J Aman","year":"2012","unstructured":"Aman J, Thunnissen E, Paul MA, van Nieuw Amerongen GP, Vonk-Noordegraaf A (2012) Successful treatment of diffuse pulmonary lymphangiomatosis with bevacizumab. Ann Intern Med 156:839\u2013840","journal-title":"Ann Intern Med"},{"key":"9595_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.mvr.2014.08.007","volume":"96","author":"SG Rockson","year":"2014","unstructured":"Rockson SG (2014) Laboratory models for the investigation of lymphangiomatosis. Microvasc Res 96:64\u201367","journal-title":"Microvasc Res"},{"key":"9595_CR32","first-page":"2592","volume":"118","author":"ZA Khan","year":"2008","unstructured":"Khan ZA, Boscolo E, Picard A et al (2008) Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Investig 118:2592\u20132599","journal-title":"J Clin Investig"},{"key":"9595_CR33","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1172\/JCI76004","volume":"125","author":"E Boscolo","year":"2015","unstructured":"Boscolo E, Limaye N, Huang L et al (2015) Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects. J Clin Investig 125:3491\u20133504","journal-title":"J Clin Investig"},{"key":"9595_CR34","doi-asserted-by":"publisher","first-page":"5281","DOI":"10.1242\/dev.00733","volume":"130","author":"S Isogai","year":"2003","unstructured":"Isogai S, Lawson ND, Torrealday S, Horiguchi M, Weinstein BM (2003) Angiogenic network formation in the developing vertebrate trunk. Development 130:5281\u20135290","journal-title":"Development"},{"key":"9595_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ng.497","volume":"42","author":"IC Cirstea","year":"2010","unstructured":"Cirstea IC, Kutsche K, Dvorsky R et al (2010) A restricted spectrum of NRAS mutations causes Noonan syndrome. Nat Genet 42:27\u201329","journal-title":"Nat Genet"},{"key":"9595_CR36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/BF00975679","volume":"7","author":"P Lanning","year":"1978","unstructured":"Lanning P, Simila S, Suramo I, Paavilainen T (1978) Lymphatic abnormalities in Noonan\u2019s syndrome. Pediatr Radiol 7:106\u2013109","journal-title":"Pediatr Radiol"},{"key":"9595_CR37","doi-asserted-by":"publisher","first-page":"8621","DOI":"10.1073\/pnas.1222722110","volume":"110","author":"PE Burrows","year":"2013","unstructured":"Burrows PE, Gonzalez-Garay ML, Rasmussen JC et al (2013) Lymphatic abnormalities are associated with RASA1 gene mutations in mouse and man. Proc Natl Acad Sci USA 110:8621\u20138626","journal-title":"Proc Natl Acad Sci USA"},{"key":"9595_CR38","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1172\/JCI46116","volume":"122","author":"PE Lapinski","year":"2012","unstructured":"Lapinski PE, Kwon S, Lubeck BA et al (2012) RASA1 maintains the lymphatic vasculature in a quiescent functional state in mice. J Clin Investig 122:733\u2013747","journal-title":"J Clin Investig"},{"key":"9595_CR39","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.ccell.2014.10.017","volume":"26","author":"PB Chapman","year":"2014","unstructured":"Chapman PB, Solit DB, Rosen N (2014) Combination of RAF and MEK inhibition for the treatment of BRAF-mutated melanoma: feedback is not encouraged. Cancer Cell 26:603\u2013604","journal-title":"Cancer Cell"},{"key":"9595_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12943-015-0293-5","volume":"14","author":"M Atefi","year":"2015","unstructured":"Atefi M, Titz B, Avramis E et al (2015) Combination of Pan-RAF and MEK inhibitors in NRAS mutant melanoma. Mol Cancer 14:27","journal-title":"Mol Cancer"},{"key":"9595_CR41","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1084\/jem.20140520","volume":"211","author":"JL Casanova","year":"2014","unstructured":"Casanova JL, Conley ME, Seligman SJ, Abel L, Notarangelo LD (2014) Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies. J Exp Med 211:2137\u20132149","journal-title":"J Exp Med"},{"key":"9595_CR42","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.1073\/pnas.0912226107","volume":"107","author":"G Buhrman","year":"2010","unstructured":"Buhrman G, Holzapfel G, Fetics S, Mattos C (2010) Allosteric modulation of Ras positions Q61 for a direct role in catalysis. Proc Natl Acad Sci USA 107:4931\u20134936","journal-title":"Proc Natl Acad Sci USA"},{"key":"9595_CR43","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrc1097","volume":"3","author":"M Malumbres","year":"2003","unstructured":"Malumbres M, Barbacid M (2003) RAS oncogenes: the first 30 years. Nat Rev Cancer 3:459\u2013465","journal-title":"Nat Rev Cancer"},{"key":"9595_CR44","doi-asserted-by":"publisher","unstructured":"Lokmic Z, Mitchell GM, Koh Wee Chong N, Bastiaanse J, Gerrand YW, Zeng Y, Williams ED, Penington AJ (2014) Isolation of human lymphatic malformation endothelial cells, their in vitro characterization and in vivo survival in a mouse xenograft model. Angiogenesis 17(1):1\u201315. https:\/\/doi.org\/10.1007\/s10456-013-9371-8","DOI":"10.1007\/s10456-013-9371-8"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10456-018-9595-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-018-9595-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-018-9595-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T21:46:54Z","timestamp":1660427214000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10456-018-9595-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,3]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["9595"],"URL":"https:\/\/doi.org\/10.1007\/s10456-018-9595-8","relation":{},"ISSN":["0969-6970","1573-7209"],"issn-type":[{"value":"0969-6970","type":"print"},{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,3]]},"assertion":[{"value":"26 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}